DOD Peer Reviewed Cancer, Career Development Award – Scholar Option
ID: 359095Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359095
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Peer Reviewed Cancer Research Program (PRCRP) Career Development Award – Scholar Option (CDA-SO) for fiscal year 2025. This grant aims to support independent early-career investigators, referred to as Scholars, in conducting impactful cancer research under the mentorship of an experienced Career Guide, with a focus on military health-related cancer issues. The program has an estimated total funding of approximately $9.9 million, with about nine awards anticipated, each capped at $1.1 million. Interested applicants must submit a pre-application by June 19, 2025, followed by a full application due by July 3, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942525PRCRPCDASO_GG.pdf
    The Department of Defense (DoD) announces the Peer Reviewed Cancer Research Program (PRCRP) Career Development Award – Scholar Option (CDA-SO) for fiscal year 2025, aimed at supporting independent, early-career investigators in significant cancer research. The program allocates approximately $9.9 million, funding about nine award applications with a cap of $1.1 million for each. Eligible applicants include both extramural and intramural organizations, focusing on specific cancer types that are relevant to military health. The application process comprises a pre-application due by June 19, 2025, followed by a full application by July 3, 2025. Key elements of the application include designation of a Career Guide for mentorship, a career development plan, and the need to demonstrate relevance to military health issues. The proposed research must address one of the designated FY25 PRCRP topic areas, which exclude melanoma and certain breast, prostate, and ovarian cancers. Unique to this award is the requirement for scholarship participation in a Virtual Cancer Center aimed at collaboration and enhanced research outcomes for cancer treatment and patient care. This funding opportunity underscores the DoD’s commitment to advancing cancer research while addressing critical needs within the military community.
    Similar Opportunities
    DOD Peer Reviewed Cancer, Clinical Trial Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity for the fiscal year 2025 under the Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA). This grant aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment, specifically targeting designated cancer types relevant to military health. The program emphasizes the importance of advancing cancer research to benefit service members, veterans, and their families, with funding available for projects ranging from initial proof-of-concept trials to large-scale phase III trials, capped at a total cost of $4.2 million over a maximum performance period of four years. Interested applicants must submit pre-applications by June 20, 2025, followed by full applications due by September 25, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD Peer Reviewed Cancer, Impact Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Peer Reviewed Cancer Research Program (PRCRP) Impact Award to support high-impact research aimed at improving clinical cancer care relevant to military health. This grant seeks mature research projects that demonstrate potential for near-term benefits in cancer treatment and patient outcomes, particularly focusing on specific cancer types such as bladder, blood, and brain cancers, while excluding melanoma and breast cancers. The program emphasizes the importance of preliminary data, collaboration with Department of Defense (DOD) and Veterans Affairs (VA) entities, and rigorous study designs to advance cancer detection and treatment for service members and their families. The estimated total program funding is $45.5 million, with individual awards capped at $1.4 million for single Principal Investigator applications and $1.75 million for partnering applications, over a maximum period of three years. Interested applicants must submit a pre-application by September 25, 2025, and can contact the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Rare Cancers, Idea Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the Rare Cancers Research Program (RCRP) Idea Development Award for fiscal year 2025. This grant aims to support innovative research that explores new ideas and develops impactful strategies in the area of rare cancers, which are defined as those affecting six or fewer individuals per 100,000 annually in the U.S. Eligible applicants include various organizations, and the program encourages interdisciplinary collaboration among military, academic, and industry sectors to enhance health outcomes for military Service Members, Veterans, and the broader public. The total estimated program funding is $6,860,000, with a funding limit of $490,000 per application. Key deadlines include a pre-application due by July 1, 2025, and a full application by October 6, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DoD Peer Reviewed Medical Research Program, Clinical Trial Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity under the Peer Reviewed Medical Research Program (PRMRP) for the fiscal year 2025, specifically for the Clinical Trial Award (CTA). This program aims to support the rapid implementation of clinical trials that can significantly impact the treatment or management of diseases relevant to military health, with a focus on areas such as autoimmune disorders, cardiovascular health, infectious diseases, and neuroscience. Approximately $32 million is available for this initiative, with an expected four awards, each capped at $8 million, and applications are due by July 21, 2025. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further assistance.
    DoD Rare Cancers, Resource and Community Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Rare Cancers Research Program Resource and Community Development Award, with an estimated total funding of $5.6 million aimed at enhancing research resources and clinical data related to rare cancers. This grant seeks to address critical gaps in rare cancer research, including the lack of resources, communication strategies, and data-sharing infrastructure, while emphasizing the integration of patient advocates throughout the project lifecycle. Eligible applicants include both domestic and foreign non-profit and for-profit organizations, with applications due by October 6, 2025, following a pre-application deadline of July 1, 2025. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DOD Ovarian Cancer, Clinical Trial Academy – Early-Career Investigator Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award for Fiscal Year 2025. This grant aims to support early-career investigators in conducting clinical trials focused on ovarian cancer, emphasizing professional development, intensive mentoring, and networking opportunities. The program is critical for enhancing the research landscape in ovarian cancer, with an estimated total funding of approximately $1.4 million available for a maximum of four years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due on September 11, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further information.
    DoD Rare Cancers, Concept Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is offering a grant opportunity under the FY25 Rare Cancers Research Program (RCRP) Concept Award, aimed at funding innovative research focused on rare cancers. This program seeks to support groundbreaking, untested studies that can potentially lead to new avenues of investigation in the field, particularly benefiting active-duty service members, veterans, military beneficiaries, and the general public. With an estimated total funding of approximately $2.38 million, individual applications can request up to $140,000, and the performance period for funded projects is capped at two years. Interested applicants must submit a Letter of Intent by July 22, 2025, followed by a full application due by August 26, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Melanoma, Melanoma Academy Scholar Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the FY25 Melanoma Academy Scholar Award to support early-career melanoma researchers. This grant aims to foster independent scientists who are within seven years of their initial faculty appointment by integrating them into a virtual collaborative academy that emphasizes mentorship and research development in melanoma. The program is particularly focused on three strategic research priorities: prevention and interception, studies on rare melanoma subtypes, and survivorship research, with a total funding allocation of approximately $1.76 million for two awards, each capped at $550,000 over a maximum period of three years. Interested applicants must submit a pre-application by September 10, 2025, followed by a full application due on October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Prostate Cancer, Idea Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Prostate Cancer Research Program (PCRP) Idea Development Award, aimed at supporting innovative research proposals that address prostate cancer challenges. This grant opportunity encourages applications from both established researchers and new investigators, with a total estimated funding of $26.4 million, including $19.2 million for established researchers and $7.2 million for new investigators, to foster advancements in understanding prostate cancer and improving patient outcomes. The application process consists of a two-step submission, with a pre-application due by August 8, 2025, and a full application due by August 29, 2025, emphasizing the importance of multidisciplinary collaborations and experienced collaborators for new investigators. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507 for further assistance.
    DoD Prostate Cancer, Clinical Consortium Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Fiscal Year 2025 Prostate Cancer Research Program Clinical Consortium Award, aimed at advancing clinical trials for novel therapeutic interventions in prostate cancer. This grant supports the establishment of a consortium of leading researchers across multiple institutions to expedite the clinical advancement of treatments, with a focus on understanding disease progression, improving patient quality of life, and ensuring equitable access to care for high-risk populations. The total estimated funding for this opportunity is approximately $36.8 million, with $12.2 million allocated for one Coordinating Center and $24.6 million for up to eleven clinical research sites, each with specific funding caps and a duration of four years. Interested applicants must submit a pre-application by August 8, 2025, followed by a full application by August 29, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.